Cointime

Hemispherian

company

About

Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.

  • 1 - 10

Highlights

Total Funding Amount
€10M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€7.50M
Industries
Biotechnology,Consulting,Health Care,Health Diagnostics
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€10M
Hemispherian has raised a total of €10M in funding over 2 rounds. Their latest funding was raised on Oct 19, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 19, 2022 Series Unknown €7.50M 1 European Innovation Council — Detail
Oct 19, 2022 Grant €2.50M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Hemispherian is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Series Unknown
Cointime
เนื้อหา
บริษัท